vs

Side-by-side financial comparison of AMERICAN REALTY INVESTORS INC (ARL) and CVRx, Inc. (CVRX). Click either name above to swap in a different company.

CVRx, Inc. is the larger business by last-quarter revenue ($16.0M vs $13.0M, roughly 1.2× AMERICAN REALTY INVESTORS INC). AMERICAN REALTY INVESTORS INC runs the higher net margin — 75.2% vs -74.5%, a 149.7% gap on every dollar of revenue. On growth, AMERICAN REALTY INVESTORS INC posted the faster year-over-year revenue change (8.1% vs 4.4%). Over the past eight quarters, CVRx, Inc.'s revenue compounded faster (22.0% CAGR vs 4.6%).

Weingarten Realty Investors was a real estate investment trust that invested in shopping centers, primarily in the Southern United States and primarily with grocery stores as the anchor stores. In August 2021, the company was acquired by Kimco Realty.

CVRx, Inc. is a commercial-stage medical technology company specializing in neuromodulation therapies for chronic cardiovascular diseases. Its flagship Barostim system treats heart failure and resistant hypertension, with core markets across North America and Europe, serving patients unresponsive to conventional drug treatments.

ARL vs CVRX — Head-to-Head

Bigger by revenue
CVRX
CVRX
1.2× larger
CVRX
$16.0M
$13.0M
ARL
Growing faster (revenue YoY)
ARL
ARL
+3.6% gap
ARL
8.1%
4.4%
CVRX
Higher net margin
ARL
ARL
149.7% more per $
ARL
75.2%
-74.5%
CVRX
Faster 2-yr revenue CAGR
CVRX
CVRX
Annualised
CVRX
22.0%
4.6%
ARL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ARL
ARL
CVRX
CVRX
Revenue
$13.0M
$16.0M
Net Profit
$9.8M
$-11.9M
Gross Margin
86.3%
Operating Margin
-23.3%
-69.8%
Net Margin
75.2%
-74.5%
Revenue YoY
8.1%
4.4%
Net Profit YoY
6175.8%
-12.0%
EPS (diluted)
$0.60
$-0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARL
ARL
CVRX
CVRX
Q4 25
$13.0M
$16.0M
Q3 25
$12.8M
$14.7M
Q2 25
$12.2M
$13.6M
Q1 25
$12.0M
$12.3M
Q4 24
$12.0M
$15.3M
Q3 24
$11.6M
$13.4M
Q2 24
$11.8M
$11.8M
Q1 24
$11.9M
$10.8M
Net Profit
ARL
ARL
CVRX
CVRX
Q4 25
$9.8M
$-11.9M
Q3 25
$129.0K
$-12.9M
Q2 25
$2.8M
$-14.7M
Q1 25
$3.0M
$-13.8M
Q4 24
$-161.0K
$-10.7M
Q3 24
$-17.5M
$-13.1M
Q2 24
$1.2M
$-14.0M
Q1 24
$1.8M
$-22.2M
Gross Margin
ARL
ARL
CVRX
CVRX
Q4 25
86.3%
Q3 25
86.8%
Q2 25
84.3%
Q1 25
83.5%
Q4 24
83.2%
Q3 24
83.2%
Q2 24
83.9%
Q1 24
85.0%
Operating Margin
ARL
ARL
CVRX
CVRX
Q4 25
-23.3%
-69.8%
Q3 25
-12.3%
-83.5%
Q2 25
-8.3%
-105.8%
Q1 25
-6.8%
-108.8%
Q4 24
-14.8%
-67.0%
Q3 24
-17.8%
-97.3%
Q2 24
-10.8%
-118.3%
Q1 24
-12.7%
-206.4%
Net Margin
ARL
ARL
CVRX
CVRX
Q4 25
75.2%
-74.5%
Q3 25
1.0%
-87.6%
Q2 25
23.2%
-108.4%
Q1 25
24.7%
-111.5%
Q4 24
-1.3%
-69.4%
Q3 24
-150.4%
-98.0%
Q2 24
9.9%
-118.8%
Q1 24
14.7%
-206.0%
EPS (diluted)
ARL
ARL
CVRX
CVRX
Q4 25
$0.60
$-0.45
Q3 25
$0.01
$-0.49
Q2 25
$0.18
$-0.57
Q1 25
$0.18
$-0.53
Q4 24
$-0.01
$-0.39
Q3 24
$-1.08
$-0.57
Q2 24
$0.07
$-0.65
Q1 24
$0.11
$-1.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARL
ARL
CVRX
CVRX
Cash + ST InvestmentsLiquidity on hand
$89.1M
$75.7M
Total DebtLower is stronger
$214.4M
Stockholders' EquityBook value
$617.4M
$39.3M
Total Assets
$1.1B
$104.8M
Debt / EquityLower = less leverage
0.35×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARL
ARL
CVRX
CVRX
Q4 25
$89.1M
$75.7M
Q3 25
$82.8M
$85.1M
Q2 25
$73.5M
$95.0M
Q1 25
$88.7M
$102.7M
Q4 24
$99.7M
$105.9M
Q3 24
$131.6M
$100.2M
Q2 24
$127.5M
$70.4M
Q1 24
$130.9M
$80.1M
Total Debt
ARL
ARL
CVRX
CVRX
Q4 25
$214.4M
Q3 25
$227.0M
Q2 25
$216.0M
Q1 25
$201.7M
Q4 24
$185.4M
Q3 24
$183.8M
Q2 24
$181.0M
Q1 24
$181.8M
Stockholders' Equity
ARL
ARL
CVRX
CVRX
Q4 25
$617.4M
$39.3M
Q3 25
$607.8M
$48.1M
Q2 25
$607.8M
$57.9M
Q1 25
$604.9M
$71.1M
Q4 24
$601.8M
$71.1M
Q3 24
$602.2M
$65.2M
Q2 24
$619.9M
$55.2M
Q1 24
$618.8M
$66.3M
Total Assets
ARL
ARL
CVRX
CVRX
Q4 25
$1.1B
$104.8M
Q3 25
$1.1B
$111.3M
Q2 25
$1.1B
$119.6M
Q1 25
$1.0B
$129.6M
Q4 24
$1.0B
$133.4M
Q3 24
$1.0B
$127.7M
Q2 24
$1.0B
$96.0M
Q1 24
$1.0B
$106.2M
Debt / Equity
ARL
ARL
CVRX
CVRX
Q4 25
0.35×
Q3 25
0.37×
Q2 25
0.36×
Q1 25
0.33×
Q4 24
0.31×
Q3 24
0.31×
Q2 24
0.29×
Q1 24
0.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARL
ARL
CVRX
CVRX
Operating Cash FlowLast quarter
$-5.6M
$-9.8M
Free Cash FlowOCF − Capex
$-9.8M
FCF MarginFCF / Revenue
-61.3%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
-0.57×
TTM Free Cash FlowTrailing 4 quarters
$-40.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARL
ARL
CVRX
CVRX
Q4 25
$-5.6M
$-9.8M
Q3 25
$8.0M
$-9.7M
Q2 25
$-2.9M
$-7.9M
Q1 25
$-7.4M
$-12.8M
Q4 24
$1.1M
$-8.0M
Q3 24
$13.5M
$-10.4M
Q2 24
$-503.0K
$-9.8M
Q1 24
$3.9M
$-10.9M
Free Cash Flow
ARL
ARL
CVRX
CVRX
Q4 25
$-9.8M
Q3 25
$-10.0M
Q2 25
$-8.0M
Q1 25
$-12.9M
Q4 24
$-8.1M
Q3 24
$-10.4M
Q2 24
$-10.2M
Q1 24
$-11.8M
FCF Margin
ARL
ARL
CVRX
CVRX
Q4 25
-61.3%
Q3 25
-68.1%
Q2 25
-59.2%
Q1 25
-104.3%
Q4 24
-52.5%
Q3 24
-78.1%
Q2 24
-86.3%
Q1 24
-109.7%
Capex Intensity
ARL
ARL
CVRX
CVRX
Q4 25
0.4%
Q3 25
2.0%
Q2 25
0.8%
Q1 25
0.9%
Q4 24
0.3%
Q3 24
0.3%
Q2 24
3.0%
Q1 24
8.5%
Cash Conversion
ARL
ARL
CVRX
CVRX
Q4 25
-0.57×
Q3 25
61.81×
Q2 25
-1.03×
Q1 25
-2.50×
Q4 24
Q3 24
Q2 24
-0.43×
Q1 24
2.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARL
ARL

Segment breakdown not available.

CVRX
CVRX

US$14.9M93%
Other$1.1M7%

Related Comparisons